Sun Pharma nears $12 billion Organon deal; announcement likely soon: Sources
Sun Pharmaceutical Industries Ltd. is close to finalising a deal to acquire assets of Organon, with an announcement expected soon, sources familiar with the matter have told CNBC-TV18. The proposed transaction is valued at over $12 billion, they said. The deal is expected to be funded through a combination of debt arranged by global banks…
